Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.

导出 OA

翻译打印收藏纠错

作者： Jay H,Kalin ^[1] ; Abdulkerim,Eroglu ^[2] ; Hua,Liu ^[3] ; W David,Holtzclaw ^[3] ; Irene,Leigh ^[4] ; Charlotte M,Proby ^[3] ; Jed W,Fahey ^[4] ; Philip A,Cole ^[3] ; Albena T,Dinkova-Kostova ^[4]

作者单位： Department of Medicine, Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States of America. ^[1] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America. ^[2] Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America. ^[3] Cullman Chemoprotection Center, Johns Hopkins University, Baltimore, MD, United States of America. ^[4] Division of Cancer Research, Jacqui Wood Cancer Centre, University of Dundee, Dundee, United Kingdom. ^[5] Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America. ^[6] Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America. ^[7]